Webinar: Open Call – Prediction of clinical trial outcome in oncology -

Dr. Yair Benita


Mati Gill


Dr. Christian Tidona

Managing Director & Founder,
Biomed X Institue

When: July 18, 2022 6:00 pm

Where: -Online


This webinar addresses FAQs about AION Labs’ 4th Call for Application, titled Prediction of Clinical Trial Outcome in Biomarker-Stratified Cancer Patient Populations, open until August 28, 2022

AION Labs, the Israel-based venture studio by AstraZeneca, Merck, Pfizer, Teva, Israel Biotech Fund, Amiti Ventures and Amazon Web Services (AWS) – powered by BioMed X – is supporting the establishment of a new, fully funded startup company in the field of clinical trial outcome prediction in biomarker-stratified cancer patient populations.

Each AION Labs startup team is sponsored by several industry-leading partners and supported by the Israel Innovation Authority. The sponsors of this call for application are AstraZeneca, Merck, Pfizer, and Teva, with close support from AWS.